RCUS ▲ +2.2% - Arcus Biosciences, Inc.
$RCUS reported Q3 2026 EPS of -$1.00, missing the -$0.90 estimate by 11.1%. Revenue of $9.0M beat the $9.0M estimate by 0.1%.
04-NOV-2026 04:26 PM ET
Share this post
More filings for $RCUS
RCUS ▲ +2.2% - Arcus Biosciences, Inc.Nov 4, 2026RCUS ▼ -1.8% - Arcus Biosciences, Inc.Nov 2, 2026RCUS ▼ -4.1% - Arcus Biosciences, Inc.Oct 26, 2026RCUS ▼ -6.3% - Arcus Biosciences, Inc.Oct 22, 2026RCUS ▼ -24.1% - Arcus Biosciences, Inc.Oct 22, 2026RCUS ▼ -23.1% - Arcus Biosciences, Inc.Oct 21, 2026
View full $RCUS filing history →💬 Comments
Loading comments…
Leave a comment